AEON Biopharma (AEON) Files $200M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- FedEx pilots ratify new collective bargaining agreement
- The real reason Meta shares are surging has nothing to do with its new AI model
- JPMorgan analysts name top short ideas for third quarter 2026
Form S-3 AEON Biopharma, Inc.
August 15, 2024 6:12 AM EDTTABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 14, 2024. Registration No. 333- UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549... More
